ArticleImmunology letters2009

A preliminary and comparative evaluation of a novel Ad5 [E1-, E2b-] recombinant-based vaccine used to induce cell mediated immune responses.

Elizabeth S Gabitzsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.